An experimental model of CCH in a previous study demonstrated that the administration of anti-HMGB1 neutralizing antibody (Ab) at the acute stage of ischemia could reserve hippocampal neuronal death and improve cognitive impairment [22]. The gene discussed is HMGB1; the disease is columnar cell hyperplasia of the breast.